HALO™ Clarity Devices Successfully Shipped for First Phase of Clinical TrialsHOUSTON, TX, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology,…
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney…
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as…
SEOUL, South Korea, Feb. 28, 2025 /PRNewswire/ -- BlueSignum, the innovator behind DailyBean, is set to launch its latest breakthrough in…
WATERLOO, ON, Feb. 27, 2025 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX) will showcase its industry-leading ability to deliver secure communications, streamlined…
Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by…
Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"…
Progress, Accomplishment, Thriving, Hope (PATH) scholarships address financial stressors affecting student mental health, retention and academic performance RESTON, Va., Feb.…
From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH…
This collaboration aims to give parents and families the tools and resources they need to live safe, balanced online lives.…